Tumor Cells, Cultured < Tumor Markers, Biological < Tumor Necrosis Factor-alpha

Facettes :

List of bibliographic references indexed by Tumor Markers, Biological

Number of relevant bibliographic references: 73.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000507 (2013)		Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micelles.
000531 (2013)		Multiplexed sandwich immunoassays using flow-injection electrochemiluminescence with designed substrate spatial-resolved technique for detection of tumor markers.
000542 (2013)		Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers.
000598 (2013)		Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.
000638 (2013)		Imaging a functional tumorigenic biomarker in the transformed epithelium.
000917 (2013)		A branched electrode based electrochemical platform: towards new label-free and reagentless simultaneous detection of two biomarkers.
000B47 (2012)		Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000C21 (2012)		Magnetic graphene nanosheets based electrochemiluminescence immunoassay of cancer biomarker using CdTe quantum dots coated silica nanospheres as labels.
000C22 (2012)		Magnetic beads-based electrochemiluminescence immunosensor for determination of cancer markers using quantum dot functionalized PtRu alloys as labels.
000C33 (2012)		Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.
001024 (2012)		(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.
001372 (2011)		Immunodevice for simultaneous detection of two relevant tumor markers based on separation of different microparticles by dielectrophoresis.
001383 (2011)		Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
001636 (2011)		A label-free immunosensor based on modified mesoporous silica for simultaneous determination of tumor markers.
001681 (2010)		Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging.
001B86 (2009)		Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma.
002070 (2008)		[Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
002145 (2008)		Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.
002173 (2008)		Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures.
002274 (2008)		Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
002410 (2008)		Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MedMesh.i -k "Tumor Markers, Biological" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MedMesh.i  \
                -Sk "Tumor Markers, Biological" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Tumor Markers, Biological
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024